Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$425.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| May 4 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 15,000 | $15.33 | $230K | -7.0% | Open the original filing on SEC.gov |
| May 4 | TRDA | Entrada Therapeutics, Inc. | MEXER◷ | 15,000 | $1.74 | $26.1K | +7.5% | Open the original filing on SEC.gov |
| Mar 10 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 11,894 | $13.05 | $155.2K | -5.7% | Open the original filing on SEC.gov |
| Mar 9 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 3,116 | $13.02 | $40.6K | -1.5% | Open the original filing on SEC.gov |
| Mar 3 | TRDA | Entrada Therapeutics, Inc. | FTAX | 14,038 | $11.76 | $165K | -6.2% | Open the original filing on SEC.gov |
| Mar 2 | TRDA | Entrada Therapeutics, Inc. | FTAX | 7,223 | $11.66 | $84.2K | -3.1% | Open the original filing on SEC.gov |
| Mar 1 | TRDA | Entrada Therapeutics, Inc. | AGRANT◆ | 83,200 | — | — | — | Open the original filing on SEC.gov |
| Mar 1 | TRDA | Entrada Therapeutics, Inc. | AGRANT | 55,800 | — | — | +31.2% | Open the original filing on SEC.gov |
| Sep 2, 2025 | TRDA | Entrada Therapeutics, Inc. | FTAX | 1,746 | $5.43 | $9.5K | -1.0% | Open the original filing on SEC.gov |